Fuisz Pharma LLC Announces Patent Issuance for its Non-Invasive Urological Device to Mitigate the Symptoms of Benign Prostate Hyperplasia (BPH)

Fuisz Pharma LLC, an affiliate of Fuisz LLC, today announced the first patent issuance for its non-invasive urological device platform to mitigate symptoms of BPH, US 11,213,41, entitled “Device and Method for Reducing Urinary Retention.” Fuisz Pharma LLC is continuing to seek additional patent protection to complement and augment the issued patent announced today.
Read more...

;